Webinars|

On-demand video: Powering the next wave of cardiometabolic care

Shl On Demand Video Cardiometabolic Care Molly Autoinjectors
With a proven track record, SHL Medical’s Molly autoinjectors are the ideal solutions to usher a new era in cardiometabolic care

Following the release of our latest article in ONdrug Delivery magazine, SHL’s Senior Manager of Portfolio Strategy and Customer Solutions, Lars Berger, discussed the pivotal role SHL Medical plays in supporting cardiometabolic care in an exclusive video.

As the global obesity epidemic the prevalence of cardiometabolic diseases continue to rise, the need for innovative healthcare solutions becomes increasingly urgent. Autoinjectors have emerged as a crucial advancement in supporting the delivery of treatments for cardiometabolic diseases, offering patients convenient and reliable means to manage their conditions at home.

Given the growing pipeline of molecules for cardiometabolic diseases, pharma and biotech companies entering this space need to seek partners with proven device technologies and globally dispersed infrastructure capable of scaling manufacturing. Berger explained in this webcast how SHL’s Molly® autoinjectors are ideally positioned to meet this challenge. Built upon a proven modular platform, Molly reduces risks during the development process while enabling flexibility in device design and production. 

Key highlights:

  • Patient-centric autoinjector technologies: Find out how SHL’s Molly autoinjectors support cardiometabolic care at the present time.
  • Extensive experience: More insights on SHL Medical’s proven track record in launching combination products for cardiometabolic diseases.
  • Scalable manufacturing: Discover how SHL’s vertically integrated manufacturing capabilities keep us ahead in the rapidly evolving field of cardiometabolic care.
  • Commitment to patients: Learn more about SHL’s dedication to providing the best user experience for cardiometabolic patients through its extensive research and development efforts.

 

 

By collaborating closely with leading pharma and biotech companies, SHL Medical continues to pioneer solutions that redefine standards in cardiometabolic care. Head to the webpage to learn more about this market-proven modular platform technology.

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News